CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1021 - 1030 of 1130
Study Number Lead Group Study Title CIRB Study Status
S1703 SWOG Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients with Metastatic Hormone Receptor Positive Breast Cancer Cancer Prevention and Control CIRB Available to Open
S1609 SWOG DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors Adult CIRB - Late Phase Emphasis Available to Open
S2104 SWOG Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors Adult CIRB - Late Phase Emphasis Available to Open
S2010 SWOG A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone To Improve Persistence With Endocrine Therapy In Young Women With Stage I-III Breast Cancer (Aspen) Cancer Prevention and Control CIRB Available to Open
S1207 SWOG Phase III Randomized; Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e3 Breast Cancer Study - evaluating everolimus with endocrine therapy Adult CIRB - Late Phase Emphasis Available to Open
S0307 SWOG Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer Adult CIRB - Late Phase Emphasis Completed
S1801 SWOG A Phase II Randomized Study of Adjuvant versus Neoadjuvant MK-3475 (Pembrolizumab) for Clinically Detectable Sage III-IV High Risk Melanoma Adult CIRB - Late Phase Emphasis Available to Open
S1505 SWOG A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/NAB-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma Adult CIRB - Late Phase Emphasis Available to Open
SWOG-9007 SWOG Cytogenetic Studies in Leukemia Patients Adult CIRB - Late Phase Emphasis Completed
S0819 SWOG A Randomized; Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Adult CIRB - Late Phase Emphasis Completed
Displaying 1021 - 1030 of 1130